These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8617182)

  • 1. Felbamate-induced headache.
    Ettinger AB; Jandorf L; Berdia A; Andriola MR; Krupp LB; Weisbrot DM
    Epilepsia; 1996 May; 37(5):503-5. PubMed ID: 8617182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerability and pharmacokinetics of monotherapy felbamate doses of 1,200-6,000 mg/day in subjects with epilepsy.
    Sachdeo R; Narang-Sachdeo SK; Shumaker RC; Perhach JL; Lyness WH; Rosenberg A
    Epilepsia; 1997 Aug; 38(8):887-92. PubMed ID: 9579889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Felbamate.
    Leppik IE
    Epilepsia; 1995; 36 Suppl 2():S66-72. PubMed ID: 8784215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Felbamate levels in patients with epilepsy.
    Harden CL; Trifiletti R; Kutt H
    Epilepsia; 1996 Mar; 37(3):280-3. PubMed ID: 8598188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coadministration of phenytoin and felbamate: evidence of additional phenytoin dose-reduction requirements based on pharmacokinetics and tolerability with increasing doses of felbamate.
    Sachdeo R; Wagner ML; Sachdeo S; Shumaker RC; Lyness WH; Rosenberg A; Ward D; Perhach JL
    Epilepsia; 1999 Aug; 40(8):1122-8. PubMed ID: 10448826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Felbamate: successful development of a new compound for the treatment of epilepsy.
    Schmidt D
    Epilepsia; 1993; 34 Suppl 7():S30-3. PubMed ID: 8243376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Felbamate urolithiasis.
    Sparagana SP; Strand WR; Adams RC
    Epilepsia; 2001 May; 42(5):682-5. PubMed ID: 11380578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discontinuation of phenytoin and carbamazepine in patients receiving felbamate.
    Wagner ML; Graves NM; Marienau K; Holmes GB; Remmel RP; Leppik IE
    Epilepsia; 1991; 32(3):398-406. PubMed ID: 1904346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Felbamate in an adult population with severe refractory epilepsy.
    Kearney H; Delanty N
    Ir Med J; 2009; 102(10):326-8. PubMed ID: 20108801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Felbamate in refractory partial epilepsy.
    Canger R; Vignoli A; Bonardi R; Guidolin L
    Epilepsy Res; 1999 Mar; 34(1):43-8. PubMed ID: 10194111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of case reports of aplastic anemia among patients treated with felbamate.
    Kaufman DW; Kelly JP; Anderson T; Harmon DC; Shapiro S
    Epilepsia; 1997 Dec; 38(12):1265-9. PubMed ID: 9578520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The long-term use of felbamate in children with severe refractory epilepsy.
    Cilio MR; Kartashov AI; Vigevano F
    Epilepsy Res; 2001 Nov; 47(1-2):1-7. PubMed ID: 11673015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticonvulsant activity of felbamate in amygdala kindling model of temporal lobe epilepsy in rats.
    Wlaź P; Löscher W
    Epilepsia; 1997 Nov; 38(11):1167-72. PubMed ID: 9579916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Felbamate: a long-term study in subjects with refractory epilepsy].
    De Romanis F; Sopranzi N
    Clin Ter; 1997 Mar; 148(3):83-7. PubMed ID: 9377844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Felbamate.
    Pellock JM
    Epilepsia; 1999; 40 Suppl 5():S57-62. PubMed ID: 10530695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Felbamate monotherapy for partial-onset seizures: an active-control trial.
    Faught E; Sachdeo RC; Remler MP; Chayasirisobhon S; Iragui-Madoz VJ; Ramsay RE; Sutula TP; Kanner A; Harner RN; Kuzniecky R
    Neurology; 1993 Apr; 43(4):688-92. PubMed ID: 8469323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Felbamate in the treatment of partial-onset seizures.
    Bourgeois BF
    Epilepsia; 1994; 35 Suppl 5():S58-61. PubMed ID: 8039474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the safety and efficacy of felbamate in the context of a black box warning: A single center experience.
    Shah YD; Singh K; Friedman D; Devinsky O; Kothare SV
    Epilepsy Behav; 2016 Mar; 56():50-3. PubMed ID: 26828692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Felbamate in the treatment of Lennox-Gastaut syndrome.
    Jensen PK
    Epilepsia; 1994; 35 Suppl 5():S54-7. PubMed ID: 8039473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Felbamate monotherapy has stimulant-like effects in patients with epilepsy.
    Ketter TA; Malow BA; Flamini R; Ko D; White SR; Post RM; Theodore WH
    Epilepsy Res; 1996 Mar; 23(2):129-37. PubMed ID: 8964274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.